Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits TGF-β induced epithelial to mesenchymal transition by Zheng, ShengXing et al.
 
 
University of Birmingham
Vitamin D attenuates lung injury via stimulating
epithelial repair, reducing epithelial cell apoptosis
and inhibits TGF- induced epithelial to
mesenchymal transition
Zheng, ShengXing; Yang, JingXiang; Hu, Xin; Li, Ming; Wang, Qian; Dancer, Rachel C A;
Parekh, Dhruv; Gao-Smith, Fang; Thickett, David R; Jin, ShengWei
DOI:
10.1016/j.bcp.2020.113955
License:
Creative Commons: Attribution (CC BY)
Document Version
Peer reviewed version
Citation for published version (Harvard):
Zheng, S, Yang, J, Hu, X, Li, M, Wang, Q, Dancer, RCA, Parekh, D, Gao-Smith, F, Thickett, DR & Jin, S 2020,
'Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell apoptosis and inhibits
TGF- induced epithelial to mesenchymal transition', Biochemical Pharmacology, pp. 113955.
https://doi.org/10.1016/j.bcp.2020.113955
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 14. Jun. 2020
Journal Pre-proofs
Vitamin D attenuates lung injury via stimulating epithelial repair, reducing
epithelial cell apoptosis and inhibits TGF-β induced epithelial to mesenchy‐
mal transition
ShengXing Zheng, JingXiang Yang, Xin Hu, Ming Li, Qian Wang, Rachel
C.A. Dancer, Dhruv Parekh, Fang Gao-Smith, David R Thickett, ShengWei
Jin
PII: S0006-2952(20)30183-0
DOI: https://doi.org/10.1016/j.bcp.2020.113955
Reference: BCP 113955
To appear in: Biochemical Pharmacology
Received Date: 13 February 2020
Accepted Date: 1 April 2020
Please cite this article as: S. Zheng, J. Yang, X. Hu, M. Li, Q. Wang, R.C.A. Dancer, D. Parekh, F. Gao-Smith,
D.R. Thickett, S. Jin, Vitamin D attenuates lung injury via stimulating epithelial repair, reducing epithelial cell
apoptosis and inhibits TGF-β induced epithelial to mesenchymal transition, Biochemical Pharmacology (2020),
doi: https://doi.org/10.1016/j.bcp.2020.113955
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover
page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version
will undergo additional copyediting, typesetting and review before it is published in its final form, but we are
providing this version to give early visibility of the article. Please note that, during the production process, errors
may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
© 2020 The Author(s). Published by Elsevier Inc.
vitamin D Attenuates lung injury via stimulating epithelial repair 
1 
 
Vitamin D attenuates lung injury via stimulating epithelial 
repair, reducing epithelial cell apoptosis and inhibits TGF-β 
induced epithelial to mesenchymal transition  
ShengXing Zheng1,*, JingXiang Yang1,*, Xin Hu1, Ming Li1, Qian Wang1, Rachel CA 
Dancer2, Dhruv Parekh2, Fang Gao-Smith 1,2, David R Thickett2** , ShengWei Jin1** 
1. Department of Anesthesia and Critical Care, The Second Affiliated Hospital and 
Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang 325027, China. 
2. Birmingham Acute Care Research Group, Institute of Inflammation and Aging, 
University of Birmingham, Birmingham B15 2TT UK. 
*, Both authors contributed equally, **, joint senior authors 
Shengxing Zheng (zsx0106014@163.com) 
Jingxiang Yang(1153669416@qq.com) 
Xin Hu (290714350@qq.com) 
Ming Li(476702675@qq.com) 
Qian Wang (wangqian84@aliyun.com) 
Rachel CA Dancer (r.dancer@bham.ac.uk) 
Dhruv Parekh (d.parekh@bham.ac.uk) 
Fang Gao-Smith (f.gaosmith@bham.ac.uk) 
David R Thickett (d.thickett@bham.ac.uk) 
Shengwei Jin (jsw@wmu.edu.cn) 
Correspondence: David R Thickett (d.thickett@bham.ac.uk) and Shengwei Jin 
(jsw@wmu.edu.cn)  telephone – sec+44 121 371 4841 fax +44 121 627 8245. 
vitamin D Attenuates lung injury via stimulating epithelial repair 
2 
 
ABSTRACT 
Vitamin D regulates cell proliferation, inhibits cytokines release at sites of 
inflammation and reduces inflammatory responses. In this study, the aim was 
to investigate whether exogenous vitamin D attenuates LPS-induced lung 
injury via modulating epithelial cell proliferation, migration, apoptosis and 
epithelial mesenchymal transition (EMT). Murine and in vitro primary type II 
alveolar epithelial cell work were included in this study. In vivo, mice were 
mildly vitamin D deficient, 0.1, 1.5, 10mg/kg 1,25(OH)2-vitamin D3 or 
25(OH)-vitamin D3 was administrated by means of an intra-gastric injection for 
14 days pre-intra-tracheal (IT) LPS, which remarkedly promoted alveolar 
epithelial type II cells proliferation, inhibited ATII cells apoptosis and inhibited 
EMT, with the outcome of attenuated LPS-induced lung injury. In vitro, vitamin 
D stimulated epithelial cell scratch wound repair, reduced primary ATII cells 
apoptosis as well. Vitamin D promoted primary human ATII cells proliferation 
through the PI3K/AKT signaling pathway and activation of vitamin D receptor 
(VDR). Moreover, vitamin D inhibited EMT in response to TGF-β, which was 
vitamin D receptor dependent. In conclusion, vitamin D attenuates lung injury 
via stimulating ATII cells proliferation and migration, reducing epithelial cell 
apoptosis and inhibits TGF-β induced EMT. Together, these results suggest 
that vitamin D has therapeutic potential for the resolution of ARDS. 
Key words: acute respiratory distress syndrome; vitamin D; alveolar type II 
cells; wound repair and apoptosis; epithelial to mesenchymal transition. 
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1. Introduction 
Acute Respiratory Distress syndrome (ARDS) characterized by alveolar 
epithelial disruption, resulting in influx of protein-rich edema fluid [1] and 
refractory hypoxia causing acute respiratory failure. Many studies suggest that 
excessive inflammation resulting in profound alveolar epithelial cell injury is 
central to the pathogenesis of ARDS [2]. This results in extensive alveolar 
epithelial cell apoptosis and increases in alveolar capillary permeability thought 
to be mediated by soluble Fas ligand (sFasL) [3]. The degree of alveolar 
epithelial injury is an important determinant of the severity of ARDS [4]. 
Therefore, the timely repair of alveolar epithelium is also thought to be pivotal 
to the resolution phase of ARDS [5]. Disordered repair mechanisms such as 
epithelial to mesenchymal transition (EMT), may be involved producing the 
fibroproliferative response seen in some patients with ARDS [6, 7]. 
Delicate alveolar sacs of the lung are composed of two main cells types, 
squamous alveolar type I (AT I) and cuboidal alveolar type II (AT II) cells [8]. AT 
I cells covering most of the alveolar surface area are more vulnerable in 
response to injury [9]. While AT II cells, acting as alveolar progenitors, 
proliferate, spread on the basement membrane, then transdifferentiate into AT 
I cells [10]. When ATII cells lose reparative mechanism, the alveolar epithelium 
damage will be repaired inpart by fibroblasts resulting in lung fibrosis at last 
[11]. Furthermore, accumulative in-vitro and animal studies provide evidence 
that AT II cells contribute to rapid and extensive alveolar repair after injury [8, 
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11, 12]. Thus, promoting ATII cells proliferation and inhibiting ATII cells 
apoptosis may be a promising way to alleviate lung injury.  
Traditionally, vitamin D is known to play a role in calcium and phosphorus 
homeostasis, bone mineralization. However, more and more evidence 
indicates that vitamin D is involved in regulating various cells of the innate and 
adaptive immune system [13]. Vitamin D has a broad role in regulating 
inflammatory responses in models of inflammations [14-16]. Vitamin D 
receptor knockout mice which were treated with LPS, displayed a more distinct 
inflammatory response than wildtype mice [17]. In addition, we previously 
demonstrated that vitamin D deficiency (VDD) contributed directly to the ARDS 
and that in a perioperative setting that vitamin D dosing reduced biomarkers of 
pulmonary vascular permeability index [18, 19]. Taken together, vitamin D may 
play a potentially beneficial role in acute lung injury (ALI). Hence, we 
investigated the specific direct effect of 1,25(OH)2-vitamin D3 or 
25(OH)-vitamin D3 upon LPS-induced lung injury. 
Concerning the protective effect of vitamin D on ALI, JUN XU et al have 
reported that a vitamin D receptor agonist, calcitriol alleviated LPS‑induced 
acute lung injury [20]. Based on JUN XU’s study, we further investigated the 
effect of 1,25(OH)2-vitamin D3 or 25(OH)-vitamin D3 on LPS‑induced acute 
lung injury, examined if mice were vitamin D deficient. Moreover, we treated 
the mice with a wide dose range of vitamin D. Importantly, we investigated if 
vitamin D could affect ATII cells proliferation, apoptosis and EMT abilities in 
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vivo as well as in vitro. Our finding revealed that exogenous vitamin D could 
exert protective effects on human lung epithelial cell in a murine LPS-induced 
lung injury.  
2. Material and Methods 
2.1 Reagents 
1,25(OH)2-vitamin D3 (the biologically active form) or 25(OH)-vitamin D3 (the 
main circulating precursor) were purchased from Sigma-Aldrich (Darmstadt, 
Germany). Recombinant human TGF-β was purchased from R&D (R&D 
Systems, Abingdon, UK). VDR ligands ZK159222 and ZK191784 were from 
Bayer Schering Pharma AG (Berlin, Germany). Antibody against caspase-3, 
AKT, phospho-AKT(Ser473) and α-SMA (48938) were obtained from Cell 
Signal Technology (Cell signal Technology, Boston, USA). Antibody against 
E-cadherin (ab1416), N-cadherin (ab18203) were obtained from Abcam 
(Abcam, Cambridge, UK). Antibody against β-actin (sc-47778) was purchased 
from Santa Cruz Biotechnology Inc (Santa Cruz, CA, USA). 25(OH) Vitamin D3 
ELISA kit (ab213966) was purchased from Abcam (Abcam, Cambridge, UK). 
Unless otherwise indicated, all other chemicals were purchased from 
Sigma-Aldrich (Shanghai, China). 
2.2 Animal and preparation 
Specific pathogen-free male C57/BL6 mice, with 24 g of mean body weight, 
obtained from Slac laboratory animal (shanghai, China), were used in all 
experiments. The study was approved by animal studies ethics committee of 
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WenZhou Medical University.  
The LPS challenge model was performed as described previously [21]. Briefly, 
mice (male; randomized into 6 groups of 6 mice per group) were anaesthetized 
and instilled by intratracheal (IT) route as a model of direct lung injury with one 
dose (0.24±0.01mg) of LPS (Escherichia coli 055: B5, Sigma-Aldrich) for 24h. 
No treatment control mice were treated with physiological saline. In certain 
groups, mice received supplementation of 0.1, 1.5, 10mg/kg 1,25(OH)2 
-vitamin D3 or 25(OH)-vitamin D3 by means of an intra-gastric injection for 14 
days pre-intratracheal (IT) LPS, while the control and LPS group mice were 
administered with physiological saline.  
2.3 Hematoxylin and Eosin (H&E) staining and lung injury score 
Briefly，the middle lobe of the right lung was fixed with 10% paraformaldehyde 
for 24 hours, embedded in paraffin wax, sectioned (5μm thickness), stained 
with hematoxylin for 5min, incubated in Scott’s tap water for 5 min and stained 
with alcoholic eosin solution for 1min. They were washed by tap water for 2 
min after every step. Then tissues were immersed in 1% hydrochloric 
acid-ethanol each for 20s. Tissues were then mounted by inversion onto glass 
slides dotted with Gel/Mount for conventional morphological evaluation under 
light microscope (Nikon eclipse 90i, Tokyo, Japan). 
A semiquantitative scoring system was adopted to evaluate the lung injury 
including alveolar congestion, alveolar hemorrhage, infiltration or aggregation 
of neutrophils in the airspace or vessel wall, and thickness of alveolar 
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wall/hyaline membrane formation and inflammatory cell infiltration. Lung injury 
scores were quantified by two investigators who was blinded to the treatment 
groups using Murray’s standard: 0 = no injury; 1 = slight injury (25%); 2 = 
moderate injury (50%); 3 = severe injury (75%); and 4 = very severe injury 
(almost 100%). 
2.4 Wet/Dry Weight Ratio  
To quantify the magnitude of pulmonary edema, we evaluated the wet weight 
to dry weight (wet/dry) ratio of the lung as described previously [22]. Briefly, 
portions of the harvested wet upper lobes of the right lung were weighed, then 
placed in an oven for 72h at 60°C until weight was no longer changed. The dry 
lungs were weighted and the wet-to-dry (W/D) ratio was calculated. 
2.5 Pulmonary barrier permeability  
Pulmonary barrier permeability was assessed by using Evans blue dye. Evans 
blue dye (20 mg/kg) was injected via the caudal vein into mice 30 min prior to 
anesthesia. After sacrifice, the lung tissues were collected and washed with 
normal saline immediately. The lung tissues were weighed after drying with 
filter paper. The Evans blue dye was extracted following homogenization in 1 
ml deionized formamide and pulverization using an ultrasonic liquid processor. 
A further 3 ml deionized formamide and 1 ml deionized formamide were added, 
and the mixture was incubated at 37°C for 48 h. The supernatant was 
separated by centrifugation at 1,000 rpm for 5 min. The quantity of dye 
extracted was determined spectrophotometrically at 620 nm and calculated 
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from a standard curve established with known amounts of Evans blue dye. 
Results are expressed as mg of dye per weight of wet tissue. 
2.6 Immunofluorescence microscopy 
Paraffin-embedded murine lung tissue sections (5 μm thickness) were 
obtained. Double labelling fluorescence techniques were used to evaluate ATII 
cells proliferation, apoptosis and EMT in the lung tissue sections. Briefly, 
paraffin-embedded sections were baked overnight at 50 ℃, deparaffinized 
with xylene and rehydrated with ethanol and water. Then the sections were 
ready for surfactant protein-C (rabbit polyclonal anti-SP-C, Sigma, USA, 
SAB4502837) and proliferating cell nuclear antigen (mouse monoclonal 
anti-PCNA, Abcam, Cambridge, UK, ab29) immunofluorescence double 
staining; surfactant protein-C and α-SMA(mouse monoclonal anti-α-SMA, Cell 
signal Technology, Boston, USA, #48938) immunofluorescence double 
staining or surfactant protein-C and TUNEL kit (In Situ Cell Death Detection Kit, 
POD Roche) immunofluorescence double staining. Nuclei were counterstained 
with 4’, 6-diamino-2-phenylindole (DAPI, Sigma-Aldrich). The intensity of the 
staining signal was measured and documented using Image-Pro Plus version6. 
0 image analysis software. We counted double positive cells in a blinded 
manner on eight randomly generated visual fields at a high magnification field 
(×400).  
2.7 The protein concentration in bronchoalveolar lavage fluid 
The protein concentration in BALF was determined using a BCA protein assay 
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kit according to the manufacturer’s instructions (Thermo Fisher Scientific, 
Waltham, MA, US). 
2.8 Vitamin D status  
Blood samples were collected from mice eyeball and centrifuged at 3000 rpm 
(soft) for 30 min at 4 °C. The serum in the upper layer was obtained. The levels 
of 25(OH)Vitamin D3 in serum were analysis using ELISA kits (ab213966, 
Abcam, Cambridge, UK) according to the manufacturer’s instructions.  
2.9 Cell culture 
Lung tissue was obtained as part of the Midlands Lung Tissue Collaborative. 
All procedures in this study were carried out in accordance with approval from 
the local research ethics committees at the University of Birmingham 
(Birmingham, UK). All patients gave written informed consent for the use of 
their tissue and clinical data for research purposes. ATII cells were isolated 
from peripheral normal lung tissue distal from the tumor in patients undergoing 
lung cancer resection. We used cells from 14 donors for ATII cell extraction 
who had normal lung function (8M:6F, mean age 62.7 years). The cells were 
isolated in accordance with approval from the local research ethics committees 
at the University of Birmingham (Birmingham, UK). Primary human alveolar 
type II (AT II) cells were extracted according to methods described previously 
[23]. Average yields of primary human alveolar type II cells were 30.2 million 
cells per resection with an average purity of 92% ATII-like cells. Cells were 
tested for primary human alveolar type II (AT II) cell phenotype by alkaline 
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phosphatase staining, lysotracker lamellar body staining and by PCR 
expression of surfactant protein C—a type II cell marker with negative 
expression of aquaporin V (a type I cell marker) (data not shown) [23]. All 
experiments were repeated in triplicate.  
2.10 Scratch wound repair and proliferation assays were performed as 
described previously [24].  
2.11 Flow cytometry 
Apoptosis of primary human alveolar type II cells was assessed as described 
previously using flow cytometry [24]. AT II cells were left in serum-free media 
for 24 hours before exposure to 100 ng/ml Fas-ligand (R&D Sytems, Abingdon, 
UK). Apoptosis was determined by flow cytometry using the Annexin V and 
SyTOX antibody according to the manufacturer’s recommendations (Molecular 
Probes, Eugene, OR) after 24 hours exposure. 
2.12 Quantitative PCR 
Real time PCR was performed using total RNA from primary human alveolar 
type II (AT II) cells (RNeasy Mini Kit; Qiagen, Hilden, Germany), the cDNA 
synthesis kit (MBI Fermentas, St. Leon-Rot, Germany), RNA (1ug) was DNase 
treated at room temperature and reverse transcribed using superscript RTase 
and random primers, according to the manufacturer’s protocol. mRNA 
expression was analyzed using Taqman primer/probe (Applied Biosystems) 
and multiplexed with 18S to account for total loading. Relative mRNA amounts 
were calculated using CT method [25] ∆CT =Ct target-Ct GAPDH, ∆∆CT =Ct 
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treatment– Ct calibrator, where calibrator was the no-treatment group. Ct was 
then converted to fold change using the formula 2-∆∆CT. Quantitative PCR was 
performed using commercially obtained primers. Details of PCR primers are 
showed in Table 1. 
2.13 Western blot analysis Western blot analysis from cells lysates were 
performed as described previously [26]. After equal amounts of protein were 
electrophoresed on 10/12% sodium dodecyl sulfate-polyacrylamide gels and 
then transferred to polyvinylidene difloride membranes (Millipore, Billerica 
MA01821). Western blot analysis was performed using the Image Quant LAS 
4000 mini (GE).  
2.14 Blinding Method  
The present study adopted randomized, blinded methods. The randomization 
list of animals was computer-generated by the statistician using SAS/STAT 
software. 
2.15 Statistical analysis 
Data were expressed as mean ± SD unless otherwise indicated. Differences 
between three or more groups were analyzed using one-way analysis of 
variance followed by the Tukey’s test for post hoc tests for variables with 
normal distribution or the Kruskal-Wallis test followed by the Dunn’s test for 
those without a normal distribution. Differences between two groups were 
analyzed using the two-tailed unpaired Student’s t-test for variables with a 
normal distribution or the Mann-Whitney test for variables without a normal 
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distribution. A p value equal or less than 0.05 was considered significant. The 
statistical analyses were performed using GraphPad Prism 5.01 (GraphPad 
Software).  
3. Results 
3.1 Vitamin D status in mice  
The serum vitamin D status were evaluated in mice with or without vitamin D 
treatment. As shown in Fig.1C, in our study, the level of serum 25(OH)-vitamin 
D3 in the no treatment mice was 14.1±3.03 ng/L,  and 21.98±1.42 ng/L in 
mice treated with 25(OH)-vitamin D3 (p=0.0002). 
3.2 Vitamin D alleviates inflammation and pulmonary permeability in the 
intratracheal LPS murine model of ALI/ARDS  
Intratracheal instillation of LPS in mice resulted in inflammatory change 
(Fig.1A, B), such as proteinaceous debris filling the airspaces, hemorrhage, 
the alveolar wall thickening, and infiltration of inflammatory cells into the 
interstitium and alveolar spaces, as evidenced by an increase in lung injury 
score. These changes in mice were further accompanied by an increase of 
W/D ratios (Fig. 1D), the protein concentration in BALF (Fig. 1E) and the 
Evans blue leakage (Fig. 1F) compared with control mice treated with NS. 
Pre-treatment with different doses (0.1, 1.5, 10mg/kg) of vitamin D significantly 
diminished histologic signs of LPS induced inflammation consistent with a 
decrease in lung injury score (Fig. 1A, B). Moreover, pre-treatment with 
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different doses (0.1, 1.5, 10mg/kg) of vitamin D dramatically decreased the 
protein concentration in BALF (Fig. 1E) and Evans blue leakage (Fig. 1F) 
stimulated by LPS. While higher concentrations of vitamin D (1.5 and 10 mg/kg) 
reduced the W/D ratio (Fig. 1D) compared with the LPS only group. The 
protective effect of moderate does (1.5mg/kg) vitamin D on ALI was greater 
compared with other groups. These results suggested that vitamin D alleviates 
lung permeability damage induced by LPS. 
3.3 Vitamin D promotes ATII cells proliferation induced by LPS in mice 
In vivo, to determine whether vitamin D has an effect on proliferation of ATII 
cells in LPS-induced lung injury, lung specimens SP-C (a type II cell marker) 
and PCNA (Proliferating Cell Nuclear Antigen) double staining 
immunofluorescence were observed (Fig. 2). SP-C/PCNA double positive cells 
remarkably decreased by LPS treatment compared with the control group (Fig. 
2B). However, 1,25-(OH)2-vitamin D3 or 25(OH)-vitamin D3 significantly 
promoted SP-C/PCNA double positive cells (proliferating ATII cells) in LPS 
induced lung injury (Fig. 2B). 
 
3.4 Vitamin D reduces ATII cells apoptosis induced by LPS in mice 
Double staining using TUNEL in conjunction with immunofluorescence for the 
type II cell marker SP-C revealed that 1,25-( OH)2-vitamin D3 or 
25(OH)-vitamin D3 significantly decreased apoptotic epithelial type II cells 
(double positive cells) in LPS induced lung injury in vivo (Fig. 3A, B). In 
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addition, there is no significance between 1,25-( OH)2-vitamin D3 or 
25(OH)-vitamin D3 groups and control group.  
3.5 Vitamin D reduces Epithelial–Mesenchymal Transition (EMT) induced 
by LPS in mice 
To determine whether vitamin D or/and LPS affect EMT in mice, lung 
specimens SP-C (a type II cell marker) and α-SMA (α-Smooth muscle actin) 
double staining immunofluorescence were observed (Fig. 4). We showed that 
SP-C/α-SMA double positive cells were remarkably increased by LPS 
treatment (Fig. 4A, B). However, pre-treatment with 1,25-( OH)2-vitamin D3 or 
25(OH)-vitamin D3 significantly decreased SP-C/α-SMA double positive cells in 
the intratracheal LPS murine model of ALI/ARDS (Fig. 4A, B). 
3.6 Vitamin D stimulates primary human ATII cells scratch wound repair 
in vitro 
Following on from previous wound repair assays [18] we assessed scratch 
wound repair over a wide dose range of vitamin D. As shown in Fig. 5, 
1,25-(OH)2-vitamin D3 or 25(OH)-vitamin D3 at physiologically relevant 
concentrations stimulated scratch wound repair in ATII cells after 36 h 
compared with control group. Scratch wound repair can happen because of 
the migration and the proliferation of cells. So next we confirmed if 
1,25-( OH)2-vitamin D3 or 25(OH)-vitamin D3 can affect primary human ATII 
cells proliferation. 
3.7 Vitamin D promotes ATII cells proliferation through the PI3K/AKT 
signalling pathway and activation of VitD receptor 
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Cell proliferation studies in vitro demonstrated that 1,25-(OH)2-vitamin D3 or 
25(OH)-vitamin D3 stimulated the proliferation of primary human ATII cells in a 
dose dependent manner (Fig. 6A). To confirm the effective involvement of 
vitamin D receptor (VDR) and PI3K/Akt pathway in the vitamin D proliferative 
response, we performed experiments in primary human ATII cells using the 
VDR antagonist ZK159222, VDR agonist ZK191784 and the PI3K/AKT 
inhibitor LY294002. Pre-treatment with LY294002 inhibited the effects of 
1,25-(OH)2-vitamin D3 on ATII cells proliferation suggesting the pro-proliferation 
effects of 1,25-(OH)2-vitamin D3 are PI3-kinase dependent (Fig. 6B). 
ZK159222 pre-treatment inhibited the effects of 1,25-(OH)2-vitamin D3 on the 
proliferation of ATII cells while ZK191784 pre-treatment promoted the effects of 
1,25-(OH)2-vitamin D3 on the proliferation of ATII cells suggesting the 
promoting proliferation effects of 1,25-(OH)2-vitamin D3 are VDR dependent 
(Fig. 6B). 
Then, we investigated if vitamin D activated AKT Phosphorylation in primary 
human ATII cells. We found that vitamin D and (or) ZK191784 (VDR agonist) 
activated AKT phosphorylation (Fig. 6C, D). 
3.8 Effect of vitamin D upon apoptosis and caspase-3 expression in 
primary human ATII cells 
Compared with PBS treatment, treatment with Soluble Fas-ligand (sFasL, 
pro-apoptotic ligands) in primary human ATII cells increased the number of 
apoptotic cells from 9.05 ±1.30% in PBS treatment to 23.28 ± 2.94% (P =0.01). 
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Rescue therapy with vitamin D reduced the number of apoptotic cells (Fig. 7A, 
B). In addition, vitamin D reduced cell death in response to sFasL and/or 
TNF-α (data not shown). Caspase-3 activation is the pivotal step in the 
pathways of apoptosis. Next, we determined if vitamin D and(or) Fas-ligand 
induced caspase-3 activation. The cleaved caspase-3 was detected by the 
western blotting analysis after the treatment of ATII cells with 100 ng/mL sFasL 
and(or) vitamin D for 24h. Fas-ligand  promoted caspase-3 activation, 
1,25-( OH)2-vitamin D3 inhibited Fas-ligand induced caspase-3 activation in 
ATII cells (Fig. 7C, D, E). 
3.9 Vitamin D inhibits TGF-β induced EMT in primary human alveolar type 
II cells through the activation of VitD receptor 
Transforming growth factor- β (TGF-β), as a central inducer of the EMT, was 
used to stimulate EMT in our study. TGF-β treatment induced profound 
mesenchymal morphology changes (fibroblast-like) in ATII cells, and 
1,25-( OH)2-vitamin D3 restored the epithelial morphology of the cells to a 
certain extent (Fig. 8A). As shown in Fig. 8B, 1,25-( OH)2-vitamin D3 promoted 
the mRNA expression of epithelial cell markers E-cadherin while inhibited the 
mRNA expression of mesenchymal cell markers including N-cadherin, 
vimentin, type I collagen, SLUG, and α-SMA. The effects of 
1,25-( OH)2-vitamin D3 on the TGF-β-induced E-cadherin, α-SMA, N-cadherin 
protein expression of ATII cells were confirmed by western blot (Fig. 8C). The 
effects of vitamin D on EMT was abrogated by the preincubation of ATII cells 
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with ZK159222 (the VitD receptor antagonist) suggesting that this effect is 
vitamin D receptor dependent (Fig. 9).  
4. Discussion 
In the present study, mice were mildly vitamin D deficient, vitamin D 
remarkedly promoted alveolar epithelial type II cells proliferation, inhibited ATII 
cells apoptosis and inhibited EMT, with the outcome of attenuated 
LPS-induced lung injury. In vitro, vitamin D also reduced primary ATII cells 
apoptosis, promoted alveolar type II (ATII) cell scratch wound repair and 
proliferation. Vitamin D also inhibited EMT in response to TGF-β through the 
activation of VitD receptor. Moreover, ZK159222 and LY294002 blocked the 
effects of vitamin D on the proliferation of ATII cells in vitro, indicating vitamin D 
promotes ATII cells proliferation through activation of vitamin D receptor, the 
PI3K/AKT signaling pathway. 
Vitamin D3, the natural form of vitamin D, is mainly formed in the skin from 
7-dehydrocholesterol, which depends on the ultraviolet irradiation. In the liver, 
vitamin D is hydroxylated by the cytochrome P-450 enzymes including 
CYP2R1, CYP27A1, and CYP2D25 to 25(OH) vitamin D3 [27]. 25(OH)vitamin 
D3 (both free and bound to its binding protein) is the major circulating vitamin 
D3 metabolite, which is widely used as one of the most reliable biomarkers of 
vitamin D status [27]. 25(OH)vitamin D3 is hydroxylated by mitochondrial 
CYP27B1 to 1,25(OH)2D3, active form of vitamin D which mediates the 
biological actions via the vitamin D receptor (VDR) [28]. Many studies have 
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reported that CYP27B1 is expressed in extrarenal sites including other tissues 
(such as placenta, parathyroid gland) and some kinds of cells (such as 
epithelial cells and immune cells) [29, 30]. Our study was based on these data, 
we found the role of both two forms of vitamin D (25(OH)-vitamin D3 and 
1,25(OH)2-vitamin D3) in animal model and ATII cells were identical suggesting 
that ATII cells could convert 25(OH)vitamin D3 to active form. 
Several studies have reported that vitamin D deficiency was associated with 
ARDS [31, 32]. Other studies have also suggested that the vitamin D/VDR 
signaling pathway had the protective function against ARDS induced by LPS 
[33, 34]. In our animal model of LPS-induced lung injury, we have 
demonstrated that increased epithelial damage was evident in response to 
LPS challenge when vitamin D deficiency is present, and vitamin D diminished 
histologic signs of LPS induced alveolar inflammation, reduced the pulmonary 
epithelial barrier permeability suggesting that vitamin D has protective effects 
on the alveolar epithelium. Importantly, our data revealed that the beneficial 
effects of moderate vitamin D were greater in those with vitamin D deficiency.  
The degree of alveolar epithelial damage is an important predictor of outcome 
in ARDS. Injury to the alveolar epithelial barrier can activate certain apoptotic 
markers of caspases and results in the excessive apoptosis of alveolar 
epithelial cells during the development of ARDS [35, 36].The restoration of the 
alveolar epithelial barrier is a critical factor for recovery in ARDS [37, 38]. 
Previous studies indicated that vitamin D played a crucial role in maintaining 
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the structure and function of epithelial barriers in many tissues [39-41]. Zhang 
H et al revealed that Vitamin D treatment greatly reduced the airway 
inflammatory response and cellular apoptosis in the lung tissue of a mouse 
model of asthma [42]. In our murine model, pre-treatment with 
1,25-( OH)2-vitamin D3 or 25(OH)-vitamin D3 stimulated alveolar epithelial cells 
proliferation and restored epithelial barriers. In addition, we also showed that 
the apoptotic type II cells (SP-C/TUNEL double positive cells) induced by LPS 
were decreased by 1,25-( OH)2-vitamin D3 as well as 25(OH)-vitamin D3. 
In our murine model, we have provided the evidence of vitamin D in promoting 
proliferation and reducing apoptosis of ATII cells, but to predict the effect of 
vitamin D on permeability of the alveolar capillary barrier in human using an 
animal model, the species difference in lung metabolism should be taken into 
consideration. In our study, primary human alveolar type II cells were used to 
assess the effect of vitamin D upon proliferation, migration and apoptosis in 
vitro. Our study clearly demonstrated that 1,25-(OH)2-vitamin D3 or 
25(OH)-vitamin D3 promoted alveolar epithelial scratch wound closure and 
proliferation of primary alveolar epithelial cells in a dose dependent manner. It 
is well-known that the PI3K-AKT signaling pathway is a key regulator of 
proliferation. Our study suggested that 1,25-(OH)2-vitamin D3 promotes 
primary human ATII cells proliferation through activation of vitamin D receptor, 
the PI3K/AKT signaling pathway, which is consistent with previous study [43]. 
Furthermore, our study showed that vitamin D inhibited apoptosis in 
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sFasL-treated primary human ATII cells, which seems to be related to the 
activation of caspase-3.   
In ARDS, the alveolar epithelial cells undergo not only apoptosis but also 
epithelial–mesenchymal transition (EMT). EMT is considered as a key 
phenomenon occurring in the lung injury which could ultimately lead to the 
prognosis of ARDS and lung fibrosis [44]. In our animal model of LPS-induced 
lung injury, we showed that ATII cells gained mesenchymal biomarkers 
(α-SMA), which was decreased by treatment with vitamin D. we also confirmed 
the above results in vitro. In TGF-β-induced primary human ATII cells, 
1,25-(OH)2-vitamin D3 promoted the expression of epithelial cell markers while 
inhibited the expression of mesenchymal cell markers. Our data is in keeping 
with recently published data in bronchial epithelia cells or Ovarian Cancer 
SKOV-3 cells treated with TGF-β [45, 46]. Fischer et al also reported that a 
vitamin D agonist, calcitriol inhibited EMT induced by TGF-β in bronchial 
epithelia cells (BEAS-2B). Similarly, we also revealed 1,25-(OH)2-vitamin D3 
inhibited EMT induced by TGF-β in primary ATII cells. Furthermore, we 
demonstrated that the effects of vitamin D on EMT was abrogated by the 
preincubation of ATII cells with ZK159222 (the vitamin D receptor antagonist) 
suggesting that this effect is vitamin D receptor dependent.  
In conclusion, our findings indicate that exogenous vitamin D attenuates lung 
injury via stimulating ATII cells proliferation and migration, reducing ATII cells 
apoptosis and inhibits TGF-β induced EMT. Our findings reveal vitamin D has 
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therapeutic potential for the resolution of ARDS which is associated with 
significant alveolar epithelial barrier damage.  
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Figure legends 
Figure 1 Vitamin D protects pulmonary histopathological changes from 
LPS induced lung injury. C57BL6 mice were instilled by intra-tracheal (IT) 
route with N.S or LPS 10mg/kg for 24h. In vitamin D groups, mice received 
supplementation of 0.1, 1.5, 10mg/kg 1,25(OH)2-vitamin D3 or 25(OH)-vitamin 
D3 by means of an intra-gastric injection for 14 days pre-intra-tracheal LPS, 
while the control and LPS groups mice were administered physiological saline. 
A: lung sections were stained with Hematoxylin-Eosin (original magnification 
×100). B: The injury scores of lung section were calculated as Murray injury 
score. The horizontal bar represents the median, and the boxes represent 
IQRs. Vertical lines show minimum–maximum range, n=6 C: The serum 
25(OH)-vitamin D3 levels in mice with or without 25(OH)-vitamin D3 treatment. 
Each dot represents an individual mouse (n=6 per group). Horizontal bars 
represent means. D, E, F: 1,25(OH)2-vitamin D3 or 25(OH)-vitamin D3 
alleviated pulmonary permeability in LPS induced acute lung injury. The 
protein concentration in BALF (D), W/D ratios(E) and the Evans blue 
leakage(F) were measured. Data are mean ± SD, n = 6. $$ p<0.01 relative to 
control group, *p<0.05, **p<0.01 compared to LPS group, #p<0.05, ##p<0.01 
compared to 0.1, 10mg/kg 1,25(OH)2-vitamin D3 or 25(OH)-vitamin D3 group. 
1,2,3 in the B, D, E, F: different concentration of 0.1, 1.5, 10mg/kg 
1,25(OH)2-vitamin D3 or 25(OH)-vitamin D3 respectively; BALF: 
Bronchoalveolar lavage fluid; W/D ratios: Wet/Dry Weight Ratios. 
vitamin D Attenuates lung injury via stimulating epithelial repair 
29 
 
Figure 2 Vitamin D promotes ATII cells proliferation induced by LPS in 
mice. C57BL6 mice were instilled by intratracheal (IT) route with N.S or LPS 
10mg/kg for 24h. In vitamin D groups, mice received supplementation of 
1.5mg/kg 1,25(OH)2-vitamin D3 or 25(OH)-vitamin D3 by means of an 
intra-gastric injection for 14 days pre-intratracheal LPS, while the control and 
LPS groups mice were administered physiological saline. A, B: 
Immunofluorescence staining of formalin fixation lung section was shot by 
fluorescence microscope and calculated by positive goals compared to nuclear 
(DAPI, blue signal). We made a co-dying of (SP-C, green signal) and (PCNA, 
red signal) ( ×400). The merged images showed a decrease of SP-C and 
PCNA fluorescence signals after exposure to LPS. Vitamin D treatment 
promoted SP-C/PCNA double positive cells (proliferating ATII cells) in LPS 
induced lung injury.  *p<0.05, **p<0.01, Data are mean ± SD. n = 6.  
 
Figure 3 Vitamin D reduces ATII cells apoptosis induced by LPS in mice.  
Mice were treated as in Figure 2. A, B: Immunofluorescence staining of 
formalin fixation lung section was shot by fluorescence microscope and 
calculated by positive goals compared to nuclear (DAPI, blue signal). We 
made a co-dying of (SP-C, green signal) and (TUNEL, red signal) (×400). The 
merged images revealed that apoptotic epithelial type II cells remarkably 
increased by LPS. However, 1,25(OH)2-vitamin D3 or 25(OH)-vitamin D3 
significantly decreased apoptotic epithelial type II cells stimulated by LPS in 
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mice. **p<0.01. Data are mean ± SD. n = 6. 
 
Figure 4 Vitamin D reduces Epithelial–Mesenchymal Transition (EMT) 
induced by LPS in mice 
Mice were treated as in Figure 2. A, B: Immunofluorescence staining of 
formalin fixation lung section was shot by fluorescence microscope and 
calculated by positive goals compared to nuclear (DAPI, blue signal). We 
made a co-dying of (SP-C, green signal) and (α-SMA, red signal) (×400). The 
merged images showed that SP-C/α-SMA double positive signal cells 
remarkably increased by LPS treatment compared with the control group. 
However, 1,25-( OH)2-vitamin D3 or 25(OH)-vitamin D3 significantly inhibited 
SP-C/α-SMA double positive signal cells. ** p<0.01. Data are mean ± SD. n = 
6. 
 
Figure 5 Vitamin D stimulates primary human ATII cells scratch wound 
repair in vitro.  
1,25(OH)2-vitamin D3 or 25(OH)-vitamin D3 at different concentrations was 
added to monolayers of primary human ATII cells physically wounded with a 
1-mL pipette tip. To allow for variability between cell batches, data are 
expressed as the mean (SE) percentage of the baseline wound size for each 
separate set of experiments for each culture condition. N=6 for each culture 
condition, repeated using cells from 3 donors. *p<0.05, **p<0.01 relative to 
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control group, #p<0.05, ##p<0.01 compared to 1,25vitD 10nM group, &p<0.05, 
&&p<0.01 compared to 25vitD 10nM group. 
 
Figure 6 Vitamin D promotes ATII cells proliferation through activation of 
vitamin D receptor, the PI3K/AKT signaling pathway. 
 A: 1,25(OH)2-vitamin D3 or 25(OH)-vitamin D3 at different concentrations 
stimulated the proliferation of primary human alveolar type II cells (ATII cells). 
Values of >1 fold of control reflect increased proliferation. N=6 for each culture 
condition, repeated using cells from 3 donors. *p<0.05, **p<0.01 relative to 
control group, ##p<0.01 compared to 1,25vitD1nM group, &&p<0.01 compared 
to 25vitD 1nM group.  
B: LY294002(a phosphatidylinositol 3'-kinase/Akt inhibitor, 10 µM), ZK159222 
(VDR antagonist, 1nM) and ZK191784 (VDR agonist, 1nM) was respectively 
pre-incubated with primary human alveolar type II cells for 1 hour before 
1,25VitD treatment of AT II cells. N=6 for each culture condition, repeated 
using cells from 3 donors. **p<0.01 relative to control group, ##p<0.01 
compared to 1,25vitD group.  
C, D: ATII cells were incubated with 1,25(OH)2-vitamin D3 and(or) ZK191784 
for 24h. Western-blot analyses were repeated using cells from 3 donors. 
**p<0.01 relative to control group.  
 
Figure 7 Effect of vitamin D upon apoptosis and caspase-3 expression in 
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primary human ATII cells.   
A, B: Primary human Alveolar Type II cells were incubated with 100 ng/mL 
sFasL and(or) vitamin D (100 nmol/ml) for 24 h. Apoptosis of the ATII cells 
were evaluated by flow cytometry analysis of annexin-positive cells. Flow 
cytometry analyses were using cells from 3 donors. *p<0.05, **p<0.01, Data 
are mean ± SEM. C, D, E: Western blots showing caspase-3 protein in primary 
human ATII cells treated with 100 ng/mL sFasL or/and 1,25VitD at 100 nM for 
24 h. Caspase-3 protein was quantified and analyzed in the indicated groups. 
Western-blot analyses were repeated using cells from 3 donors. **p<0.01, 
Data are mean ± SEM. 
  
Figure 8 Vitamin D inhibits TGF-β induced EMT in Primary human 
alveolar type II cells 
Primary human ATII cells were pre-treated with vitamin D for 2 h. The cells 
were then cultured with TGF-β (10 ng/ml) for 48h. The Real-time PCR and 
Western-blot analyses were repeated using cells from 3 donors. A: 
Phase-contrast images of ATII cells. After incubation, the cells were 
photographed using the Real time image system under a Leica microscope 
(Original magnification ×200). B: The mRNA expression of E-cadherin, 
N-cadherin, vimentin, type I collagen, SLUG, and α-SMA were assessed by 
Real-time Quantitative PCR Detecting System. *p<0.05 relative to control 
group respectively, #p<0.05 compared to TGF-β group respectively. C: The 
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protein expression of E-cadherin, N-cadherin and α-SMA by Western Blot and 
analyzed by densitometry compared to β-actin. **p<0.01. 
 
Figure 9 Vitamin D inhibits TGF-β induced EMT in primary human 
alveolar type II cells via vitamin D receptor（VDR）.  
ZK159222 (VDR antagonist, 1nM) was pre-incubated with primary human 
alveolar type II cells for 1 hour prior to 1,25VitD and TGF-β treatment. After 
ZK159222 treatment, primary human ATII cells were pre-treated with vitamin D 
(100nM/ml) for 2h and then cultured with TGF-β (10 ng/ml) for 48h. The protein 
expression of E-cadherin and N-cadherin by Western Blot and analyzed by 
densitometry compared to β-actin. Western-blot analyses were repeated using 
cells from 3 donors. *p<0.05, **p<0.01. 
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Table1 Details of primers used in Real-time PCR 
Gene name Accession 
number 
Forward primer Reverse primer 
Homo sapiens Vimentin NM_003380 CTTCAGAGAGAGGAA
GCCGA 
ATTCCACTTTGCGTTC
AAGG 
Homo sapiens 
snail-homolog-2 (SLUG) 
NM_003068 CAGACCCTGGTTGCTT
CAA 
TGACCTGTCTGCAAA
TGCTC 
Homo sapiens collagen, 
type I, alpha 1 
NM_000088 CTTTGCATTCATCTCT
CAAACTTAGTTTT 
CCCCGCATGGGTCTT
CA 
Homo sapiens actin, 
alpha 2, smooth muscle, 
aorta (ACTA2) 
NM_001613 CCGACCGAATGCAGA
AGGA 
ACAGAGTATTTGCGC
TCCGAA 
Homo sapiens cadherin 
1, type 1, E-cadherin 
(epithelial) (CDH1) 
NM_004360 GGTCTCTCTCACCACC
TCCA 
CCTCGGACACTTCCA
CTCTC 
Homo sapiens cadherin 
2, type 1, N-cadherin 
(epithelial) (CDH2) 
 NM_007664 CGTGAAGGTTTGCCA
GTGT 
CAGCACAAGGATAAG
CAGGA 
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